Southport Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $674K | Buy |
9,234
+3,454
| +60% | +$232K | 0.25% | 114 |
|
|
2021
Q4 | $360K | Buy |
5,780
+195
| +3% | +$11.4K | 0.06% | 228 |
|
|
2021
Q3 | $330K | Sell |
5,585
-3,082
| -36% | -$203K | 0.13% | 172 |
|
|
2021
Q2 | $579K | Sell |
8,667
-156
| -2% | -$10.2K | 0.14% | 170 |
|
|
2021
Q1 | $557K | Buy |
8,823
+623
| +8% | +$38.8K | 0.15% | 177 |
|
|
2020
Q4 | $509K | Sell |
8,200
-1,196
| -13% | -$73.5K | 0.18% | 127 |
|
|
2020
Q3 | $567K | Sell |
9,396
-231
| -2% | -$13.9K | 0.22% | 120 |
|
|
2020
Q2 | $566K | Buy |
9,627
+902
| +10% | +$54K | 0.24% | 109 |
|
|
2020
Q1 | $486K | Buy |
8,725
+1,076
| +14% | +$65.8K | 0.26% | 109 |
|
|
2019
Q4 | $491K | Buy |
7,649
+316
| +4% | +$18.1K | 0.19% | 126 |
|
|
2019
Q3 | $372K | Buy |
7,333
+402
| +6% | +$18.9K | 0.17% | 132 |
|
|
2019
Q2 | $314K | Sell |
6,931
-647
| -9% | -$30.1K | 0.14% | 146 |
|
|
2019
Q1 | $362K | Buy |
7,578
+5
| +0.1% | +$249 | 0.16% | 132 |
|
|
2018
Q4 | $394K | Buy |
7,573
+60
| +0.8% | +$3.22K | 0.2% | 121 |
|
|
2018
Q3 | $466K | Buy |
7,513
+353
| +5% | +$20.9K | 0.2% | 120 |
|
|
2018
Q2 | $396K | Sell |
7,160
-196
| -3% | -$10.6K | 0.18% | 129 |
|
|
2018
Q1 | $465K | Sell |
7,356
-5,093
| -41% | -$328K | 0.21% | 127 |
|
|
2017
Q4 | $763K | Buy |
12,449
+5,512
| +79% | +$345K | 0.29% | 98 |
|
|
2017
Q3 | $442K | Buy |
6,937
+308
| +5% | +$18K | 0.19% | 118 |
|
|
2017
Q2 | $369K | Buy |
6,629
+205
| +3% | +$11.2K | 0.16% | 131 |
|
|
2017
Q1 | $349K | Sell |
6,424
-102
| -2% | -$5.59K | 0.2% | 118 |
|
|
2016
Q4 | $381K | Buy |
6,526
+7
| +0.1% | +$383 | 0.23% | 110 |
|
|
2016
Q3 | $352K | Sell |
6,519
-400
| -6% | -$25.7K | 0.25% | 112 |
|
|
2016
Q2 | $509K | Hold |
6,919
| – | – | 0.28% | 100 |
|
|
2016
Q1 | $442K | Hold |
6,919
| – | – | 0.28% | 95 |
|
|
2015
Q4 | $476K | Sell |
6,919
-300
| -4% | -$19.8K | 0.31% | 90 |
|
|
2015
Q3 | $427K | Buy |
7,219
+610
| +9% | +$38.7K | 0.29% | 98 |
|
|
2015
Q2 | $440K | Sell |
6,609
-204
| -3% | -$13.4K | 0.27% | 101 |
|
|
2015
Q1 | $439K | Sell |
6,813
-899
| -12% | -$56.3K | 0.26% | 98 |
|
|
2014
Q4 | $455K | Sell |
7,712
-799
| -9% | -$45.1K | 0.27% | 94 |
|
|
2014
Q3 | $436K | Sell |
8,511
-99
| -1% | -$4.95K | 0.29% | 88 |
|
|
2014
Q2 | $418K | Buy |
8,610
+450
| +6% | +$22.2K | 0.28% | 91 |
|
|
2014
Q1 | $424K | Sell |
8,160
-6,300
| -44% | -$335K | 0.3% | 87 |
|
|
2013
Q4 | $769K | Buy |
14,460
+8,700
| +151% | +$443K | 0.54% | 61 |
|
|
2013
Q3 | $267K | Hold |
5,760
| – | – | 0.21% | 108 |
|
|
2013
Q2 | $257K | Buy |
+5,760
| New | +$250K | 0.21% | 113 |
|
Other funds holding BMY
Southport Capital Management's BMY Position: Q1 2022 in Review
Southport Capital Management increased its Bristol-Myers Squibb (BMY) stake by 60% in Q1 2022, buying an estimated $232K and bringing the position to 9,234 shares worth $674K. The position accounts for 0.25% of the portfolio, ranked #114.
Southport Capital Management first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $769K in Q4 2013. 2,516 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Southport Capital Management held 9,234 shares of Bristol-Myers Squibb worth $674K as of Q1 2022.
- Southport Capital Management bought 3,454 Bristol-Myers Squibb shares in Q1 2022, an estimated $232K.
- Bristol-Myers Squibb made up 0.25% of Southport Capital Management's portfolio in Q1 2022, its #114 holding.
- Southport Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- Southport Capital Management's Bristol-Myers Squibb position peaked at $769K in Q4 2013.
- 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.